Collects samples and data from people with amyloid diseases
Stores blood, urine and tissue samples from adults with amyloid diseases for future study.
Plain-language title generated from the registry record
Registry title: Collection of Samples and Clinical Data From Patients With Amyloid Diseases
Key facts
- Where
- Boston, United StatesSee the site
AI summary: who the study is looking for
From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.
The trial is looking for adults who have amyloidosis or may have it, and who were referred to the Amyloid Treatment and Research Center at Boston University Medical Center. Samples and data are collected for future research.
- Age
- 18 Years and older
- Sex
- Men and women
- Disease stage
- Diagnosis or suspicion of amyloidosis
Read by machine on 9 November 2026.
Where in United States
- Boston University Cancer Research CenterBoston, United StatesTaking people
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Trial details
- Who runs it
- Boston Medical Center
- Trial code
- NCT00898235
- Record updated
- 1 December 2025
- Original description
RATIONALE: Collecting and storing samples of blood, urine, tissue and data from patients with amyloid diseases to test in the laboratory may help the study of this disease in the future.Read full original descriptionShow less
Data, Tissue, Blood, and Urine Repository for Amyloid Diseases
RATIONALE: Collecting and storing samples of blood, urine, tissue and data from patients with amyloid diseases to test in the laboratory may help the study of this disease in the future.
PURPOSE: This research study is collecting samples from patients with amyloid diseases
Inclusion: DISEASE CHARACTERISTICS:; Diagnosis or suspicion of amyloidosis; PATIENT CHARACTERISTICS:; Referred to the Amyloid Treatment and Research Center at Boston University Medical Center; PRIOR CONCURRENT THERAPY:; Not specified.
Exclusion: None.